Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) issued its 2026 annual shareholder update outlining a roadmap of short-, near- and long-term goals as it advances AI-driven consumer, wellness, and medical applications.

Short-term: launch first consumer AI mobile app across 127 countries in 30 languages, establish a direct revenue stream, name and brand the app, and continue prototype development; subsidiaries Infinite Auctions and Real Game Used will keep generating revenue.

Near-term (2026): release medical-grade beta apps, run structured beta testing with Arizona State University medical student groups, and advance clinical-grade efficacy testing under medical supervision.

Long-term (2027+): pursue an OTCQB uplisting if qualified, complete a provisional patent for its AI image analysis, explore clinical/institutional partnerships and regulatory pathways, and evaluate separate tickers for subsidiaries once sustained revenue is achieved.

News Market Reaction

%

1 alert

% News Effect

On the day this news was published, MDCE declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MESA, AZ / ACCESS Newswire / January 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-focused company developing AI-driven consumer, wellness, and medical applications, today provided its 2026 annual shareholder update outlining its short-term, near-term, and long-term strategic goals as the Company advances its next phase of growth. These updates are also updated on our corporate website www.medicalcaretechnologies.com.

Short-Term Goals (Coming Weeks / Months)

Launch the Company's first completed consumer-based AI mobile application across 127 countries and 30 languages, demonstrating scalability, revenue potential, and global reach.

Establish MDCE's first direct, non-subsidiary revenue stream through consumer AI applications.

Announce the official name and branding of the first consumer app, accompanied by a coordinated launch campaign.

Outline plans for multiple upcoming AI applications across health, wellness, and dietary categories to support near-term revenue generation.

Continue development and testing of AI-based mobile applications addressing consumer and medical needs, including projects currently in prototype stages to be announced at a later date.

Subsidiaries Infinite Auctions and Real Game Used to continue generating revenue through high-value collectible sales and AI-based authentication services, respectively.

Near-Term Goals (2026)

Develop and release one or more medical-grade beta applications.

Conduct structured beta testing in collaboration with Arizona State University medical student groups.

Advance select applications into clinical-grade efficacy testing with patient testing and a follow-up round supervised my medical professionals.

Continue expanding the Company's and other AI platform capabilities to support both consumer and medical use cases.

Long-Term Goals (2027 and Beyond)

Pursue an uplisting to OTCQB, subject to meeting qualification standards, to enhance corporate credibility, transparency, and investor access.

Complete the Company's provisional patent related to its patent-pending AI image analysis process.

Explore clinical and institutional partnerships for medical-focused applications.

Seek clinical validation and/or FDA-style regulatory pathways for one or more medical-grade AI applications, where applicable.

Evaluate future plans for subsidiaries Infinite Auctions and Real Game Used to operate under their own ticker symbols once MDCE achieves sustained, meaningful revenue growth.

The Company believes that its consumer-focused AI applications can help support operations and growth while it advances through the longer development, testing, and approval timelines required for medical-grade technologies.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK:MDCE) is a technology company focused on developing AI-driven applications across consumer health, wellness, dietary, and medical markets. The Company also owns revenue-generating subsidiaries Infinite Auctions and Real Game Used.

Websites:
www.medicalcaretechnologies.com I www.mdcestock.com

Contact Information:
Address: MEDICAL CARE TECHNOLOGIES INC. 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204 Email: info@infiniteauctions.com, Phone: 480-645-0750

Subsidiaries Websites: www.infiniteauctions.com I www.realgameused.com

Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are based on current expectations and assumptions that are subject to risks, uncertainties, and factors that could cause actual results to differ materially. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What consumer app will Medical Care Technologies (MDCE) launch in 2026?

The company plans to launch its first consumer AI mobile application across 127 countries in 30 languages; the official name and branding will be announced at launch.

How will MDCE generate revenue from its consumer AI applications in 2026?

MDCE expects to establish its first direct, non-subsidiary revenue stream through consumer AI applications tied to the upcoming app launches.

What medical testing does MDCE plan for 2026 for medical-grade apps?

MDCE intends to develop medical-grade beta applications, conduct structured beta testing with Arizona State University medical student groups, and advance to clinical-grade efficacy testing supervised by medical professionals.

Is MDCE pursuing regulatory approval or clinical validation for its AI medical tools?

The company plans to seek clinical validation and/or FDA-style regulatory pathways where applicable for one or more medical-grade AI applications.

Will Medical Care Technologies (MDCE) seek an uplisting and when?

MDCE intends to pursue an OTCQB uplisting in the long term (2027 and beyond), subject to meeting the exchange's qualification standards.

What intellectual property steps is MDCE taking for its AI technology?

The company plans to complete a provisional patent related to its patent-pending AI image analysis process as part of its long-term roadmap.